Frontiers in Cardiovascular Medicine (Feb 2022)

Machine Learning Using a Single-Lead ECG to Identify Patients With Atrial Fibrillation-Induced Heart Failure

  • Giorgio Luongo,
  • Felix Rees,
  • Deborah Nairn,
  • Massimo W. Rivolta,
  • Olaf Dössel,
  • Roberto Sassi,
  • Christoph Ahlgrim,
  • Louisa Mayer,
  • Franz-Josef Neumann,
  • Thomas Arentz,
  • Amir Jadidi,
  • Axel Loewe,
  • Björn Müller-Edenborn

DOI
https://doi.org/10.3389/fcvm.2022.812719
Journal volume & issue
Vol. 9

Abstract

Read online

AimsAtrial fibrillation (AF) and heart failure often co-exist. Early identification of AF patients at risk for AF-induced heart failure (AF-HF) is desirable to reduce both morbidity and mortality as well as health care costs. We aimed to leverage the characteristics of beat-to-beat-patterns in AF to prospectively discriminate AF patients with and without AF-HF.MethodsA dataset of 10,234 5-min length RR-interval time series derived from 26 AF-HF patients and 26 control patients was extracted from single-lead Holter-ECGs. A total of 14 features were extracted, and the most informative features were selected. Then, a decision tree classifier with 5-fold cross-validation was trained, validated, and tested on the dataset randomly split. The derived algorithm was then tested on 2,261 5-min segments from six AF-HF and six control patients and validated for various time segments.ResultsThe algorithm based on the spectral entropy of the RR-intervals, the mean value of the relative RR-interval, and the root mean square of successive differences of the relative RR-interval yielded an accuracy of 73.5%, specificity of 91.4%, sensitivity of 64.7%, and PPV of 87.0% to correctly stratify segments to AF-HF. Considering the majority vote of the segments of each patient, 10/12 patients (83.33%) were correctly classified.ConclusionBeat-to-beat-analysis using a machine learning classifier identifies patients with AF-induced heart failure with clinically relevant diagnostic properties. Application of this algorithm in routine care may improve early identification of patients at risk for AF-induced cardiomyopathy and improve the yield of targeted clinical follow-up.

Keywords